Pacific Biosciences Of California Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 5.04, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Pacific Biosciences Of California Inc in Jun 30 2026 quarter, has decreased to 72 days, compared to 73 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 425 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2535 to 2878.

What is Receivable Turnover Ratio?
What is Pacific Biosciences Of California Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PACB Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-3.57 %	-7.25 %	28.79 %	4.2 %	-0.54 %
Y / Y Revenue Change	-1.71 %	0.58 %	13.75 %	-2.83 %	10.42 %
Receivable Turnover Ratio (TTM)	5.04	5.01	4.92	5.06	5.14
PACB's Total Ranking	# 2878	# 2535	# 1763	# 2104	# 2252
Accounts Receivable average collection period days	72	73	74	72	71
Seq. Receivable Change	5.98 %	-17.2 %	15.78 %	-5.09 %	1.93 %
Seq. Revenue Change	5.88 %	-19.15 %	20.22 %	-4.49 %	8.34 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 18
Healthcare Sector	# 426
Overall Market	# 2878

Receivable Turnover Ratio Statistics
High	Average	Low
0.85	0.33	0.07
(Dec 31 2015)		(Dec 31 2022)

PACB Company Profile • Back to PACB Efficiency Comparisons • Compare PACB Receivables Turnover Ratio to its Competitors

Financial Statements
Pacific Biosciences Of California Inc 's Accounts Receivable	$ 31 Millions	Visit PACB's Balance sheet
Pacific Biosciences Of California Inc 's Sales TTM	$ 159 Millions	Visit PACB's Income Statement
Sources of PACB's Revenues		Visit PACB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PACB's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PACB's Growth Rates	PACB's Roa	PACB's Inventory Turnover Ratio	PACB's Dividend Comparisons
PACB's Profitability Ratios	PACB's Roi	PACB's Asset Turnover Ratio	PACB's Dividend Growth
PACB's Valuation Ratios	PACB's Roe	PACB's Financial Strength Ratios	PACB's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
10x Genomics Inc	13.90	$ 616.566 Millions	$ 44.342 Millions
Amneal Pharmaceuticals Inc	13.90	$ 3,117.474 Millions	$ 224.342 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Corcept Therapeutics Inc	13.54	$ 830.813 Millions	$ 61.352 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Nrc Health	12.72	$ 139.996 Millions	$ 11.004 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.98	$ 8.855 Millions	$ 0.739 Millions
Teladoc Health Inc	11.88	$ 2,489.480 Millions	$ 209.556 Millions
Premier Air Charter Holdings Inc	11.72	$ 31.562 Millions	$ 2.692 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Vaso Corporation	11.31	$ 80.220 Millions	$ 7.094 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Lifeloc Technologies Inc	11.19	$ 9.269 Millions	$ 0.828 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Radnet Inc	10.53	$ 2,268.932 Millions	$ 215.450 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.